Clinical Trial Update: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease [Phase 2]

View source ↗

Summary

The study provides Phase 2 results on the effectiveness and safety/toxicity of CyberKnife-based radiosurgery for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN